112 related articles for article (PubMed ID: 10782690)
1. Incorporation of a 4-hydroxy-N-acetylprolinol nucleotide analogue improves the 3'-exonuclease stability of 2'-5'-oligoadenylate-antisense conjugates.
Verheijen JC; van Roon AM; Meeuwenoord NJ; Stuivenberg HR; Bayly SF; Chen L; van der Marel GA; Torrence PF; van Boom JH
Bioorg Med Chem Lett; 2000 Apr; 10(8):801-4. PubMed ID: 10782690
[TBL] [Abstract][Full Text] [Related]
2. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
[TBL] [Abstract][Full Text] [Related]
3. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
4. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
5. 2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L.
Verheijen JC; van der Marel GA; van Boom JH; Bayly SF; Player MR; Torrence PF
Bioorg Med Chem; 1999 Mar; 7(3):449-55. PubMed ID: 10220031
[TBL] [Abstract][Full Text] [Related]
6. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
Ueno Y; Ishihara S; Ito Y; Kitade Y
Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2',5'-oligoadenylate analogs possessing a linker moiety in the place of the second adenosine and their ability to activate human RNase L.
Nakamura T; Ito Y; Mochizuki M; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2007; (51):449-50. PubMed ID: 18029780
[TBL] [Abstract][Full Text] [Related]
9. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Bioorg Med Chem Lett; 2003 Nov; 13(22):3959-61. PubMed ID: 14592484
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
[TBL] [Abstract][Full Text] [Related]
12. Convergent synthesis of ribonuclease L-active 2',5'-oligoadenylate-peptide nucleic acids.
Wang Z; Chen L; Bayly SF; Torrence PF
Bioorg Med Chem Lett; 2000 Jun; 10(12):1357-60. PubMed ID: 10890163
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases.
Li G; Xiao W; Torrence PF
J Med Chem; 1997 Aug; 40(18):2959-66. PubMed ID: 9288179
[TBL] [Abstract][Full Text] [Related]
14. Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.
Silverman RH; Dong B; Maitra RK; Player MR; Torrence PF
Methods Enzymol; 2000; 313():522-33. PubMed ID: 10595377
[No Abstract] [Full Text] [Related]
15. Synthesis and biological activities of 8-substituted 2-5A analogues.
Nagai K; Yokoyama S; Kawai G; Shuhadlnik RJ; Takaku H
Nucleic Acids Symp Ser; 1990; (22):13-4. PubMed ID: 2101896
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
Yoshimura A; Nakanishi M; Yatome C; Kitade Y
J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
[TBL] [Abstract][Full Text] [Related]
17. Using fluorescence resonance energy transfer (FRET) for measuring 2-5A analogues ability to activate RNase L.
Cramer H; Geselowitz DA; Torrence PF
Nucleosides Nucleotides; 1999; 18(6-7):1523-5. PubMed ID: 10474231
[TBL] [Abstract][Full Text] [Related]
18. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
[No Abstract] [Full Text] [Related]
19. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for recognition of 2',5'-linked oligoadenylates by the N-terminal ankyrin repeat domain of human ribonuclease L.
Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
Nucleic Acids Symp Ser (Oxf); 2005; (49):323-4. PubMed ID: 17150764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
